Dengue subunit vaccine (Merck Sharp & Dohme)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameDengue subunit vaccine (Merck Sharp & Dohme)
Drug Alias NameTetravalent dengue vaccine (Merck Sharp & Dohme)HBV-001-D1DEN-1-80EV-180HB-6
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHawaii Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHawaii Biotech IncNational Institute Of Allergy And Infectious Diseases (Niaid)Merck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsDengue

Other Information

ATC CodeN/A
Related LinksN/A